Skip to main content

Becton Dickinson Value Stock - Dividend - Research Selection

Becton dickinson

ISIN: US0758871091 , WKN: 857675

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women\'s health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Best Dividend Aristocrats For October 2025

2025-09-28
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now.

Dividend Champion, Contender, And Challenger Highlights: Week Of September 28

2025-09-26
Read the latest dividend updates for Dividend Champions, Contenders, and Challengers. Track changes, ex-dividend, and pay dates.

RBC starts Becton Dickinson at Sector Perform, sees limited upside until 2027

2025-09-25
Investing.com -- RBC Capital Markets initiated coverage of Becton, Dickinson and Company with a Sector Perform rating and a $211 price target, saying the medical device maker’s growth acceleration is more likely to come after 2026.

Why BD (BDX) Shares Are Falling Today

2025-09-25
Shares of medical technology company Becton, Dickinson and Company (NYSE:BDX) fell 4.2% in the morning session after RBC Capital initiated coverage on the company with a neutral 'Sector Perform' rating.

Oracle initiated, Ulta Beauty upgraded: Wall Street's top analyst calls

2025-09-25
Oracle initiated, Ulta Beauty upgraded: Wall Street's top analyst calls

RBC Capital Initiates Coverage of Becton, Dickinson and (BDX) with Sector Perform Recommendation

2025-09-25

Best Dividend Kings: September 2025

2025-09-24
Discover which Dividend Kings outperformed the SPY in 2024, top stock picks, growth outlooks, and find undervalued opportunities.

HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?

2025-09-24
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.

Becton Dickinson (BDX): Evaluating Valuation as Stock Momentum Shifts and Fundamentals Stay Strong

2025-09-24
Becton Dickinson (NYSE:BDX) has been in the spotlight recently, and investors are understandably looking for signals amid the recent price moves. There might not be a single headline-grabbing event, nothing dramatic in the news or radical in company fundamentals, but the ongoing shifts in the share price have caught the eye of anyone tracking healthcare stocks. Sometimes, it's the quieter stretches that demand the closest attention, especially when a stock with Becton Dickinson’s reputation...

Investors in Becton Dickinson (NYSE:BDX) have unfortunately lost 20% over the last year

2025-09-24
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...